Se connecter
S'abonner en ligne
La Synthèse on line
Accueil
Idées
Macro
Développt.Durable
Micro-éco
Changes
Taux
Matières Premières
OPCVM
Company news
Fund news
E-Mail alert service
Notre offre
All stories
All companies
Advanced search
All communications of ABSCIENCES
ABSCIENCES
[FR0010557264 / AB]
Fiche de la société
Tweeter
AB Science provides the summary of webcast with Key Opinion Leaders on masitinib Phase 3 results in severe asthma uncontrolled by oral corticosteroids
INFORMATION REGLEMENTEE
[02/12/2019 | 22:31]
Read all communications published by ABSCIENCES
Videos
Gestionnaires,
Emetteurs,
My favourite companies
Most read news of ABSCIENCES
